Rupa 10Mg

Composition Each Tablet contains Rupatadine Fumarate INN equivalent to Rupatadine 10 mg. 

Pharmacology: Rupatadine is a long-acting, non-sedative antagonist of histamine HI-receptors. It also antagonizes the platelet-activating factor (PAF). Both histamine and PAF cause bronchoconstriction which leads to an increase in the vascular permeability and act as a mediator in the inflammatory process. With the dual mode of action, Rupatadine shows better therapeutic effect than an isolated antihistamine. Rupatadine possesses other anti-allergic properties such as the inhibition of the degranulation of mast cells induced by immunological and non-immunological stimuli and inhibition of the release of cytokines, particularly of the tumor necrosis factor alpha (TNF u) in human mastocytes and monocytes. 

Indications: Rupatadine is indicated for the symptomatic treatment of seasonal & perennial allergic rhinitis and urticaria. 

Contraindications: Hypersensitivity to Rupatadine or to any of the excipients. 

Side effects: The most common undesirable effects are sleepiness, general weakness & fatigue. Other uncommon undesirable effects include dyspepsia, rash and increased appetite. 

Precautions: Administration of a dose of 10 mg daily of Rupatadine has not shown significant effects on the function of the central nervous system as seen in specific studies done for psychomotor function. Nevertheless, the patient should take precaution in driving or managing machines. 

Use in special group: Pregnancy & Lactation: There is no clinical data available on the exposure of Rupatadine during pregnancy. Studies in animals did not show direct or indirect damaging effects, which refer to the pregnancy, embryonic/fetal development, delivery or pre-natal development. Pregnant women should therefore not use Rupatadine, unless the potential benefit outweighs the potential risk for the fetus. No information is available, whether Rupatadine is excreted in the mother's milk. Therefore, it should not be used during lactation, unless the potential benefits for the mother justify the potential risk to the infant. 

Elderly: Rupatadine should be used with caution in elderly. 

Patients with renal or hepatic insufficiency: Use of Rupatadine is not recommended in patients with renal or hepatic insufficiency, as no relevant clinical data is available. 

Drug interactions: CYP3A4 inhibitors like Erythromycin & Ketoconazole inhibits both the presystolic and systemic metabolism of Rupatadine. Due to this potential interaction, it is not recommended to use Rupatadine in combination with Ketoconazole, macrolides or any other inhibitors of CYP3A4. Co administration of Rupatadine and CNS depressants or alcohol may increase CNS depressant effect. 

Manufactured by: ARISTOPHARMA LTD